Global Pediatric Heart Failure Market, By Treatment (Diuretics, Digoxin, Aldosterone Antagonists, ACE Inhibitors, Beta Blockers, Inotropes), Type (Over- Circulation Failure, Pump Failure), End-Users (Clinics, Hospitals, Ambulatory Surgical Centers, Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacy, Others), Country (U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa) Industry Trends and Forecast to 2028
Market Analysis and Insights: Global Pediatric Heart Failure Market
Pediatric heart failure market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses the market is growing at a CAGR of 4.90% in the above-mentioned research forecast period. Rising incidences of congenital heart defects and increasing demand of non- invasive treatment options.
Moreover exploration of emerging markets and launch of novel heart failure medicines in order to fulfil the unmet needs also boost up the market growth. Moreover, vigorous research and development efforts and rising healthcare expenditure act as opportunity for the market growth. But, sometimes adverse effect related to heart failure drugs, complex drug development process and strict regulations may hamper the global pediatric heart failure market.
Heart failure in children is different from that of the heart failure in adults, as heart failure in children mostly occurs due to congenital heart disease (CHD) and cardiomyopathy. Pediatric heart failure is characterized by respiratory distress, exercise intolerance, edema, growth failure, neurohormonal and molecular derangements. Pediatric heart failure has been categorized into two groups that involves pump failure and over circulation failure. Over circulation results due to hypercontractile of left ventricles, moreover pulmonary arterial or venous hypertension also reported in patients. However pump failure occurs due to acquired and congenital conditions and most patients have pulmonary venous hypertension. Pediatric heart failure can be using diuretics, inotropes, digoxin, ACE inhibitors, beta blockers, aldosterone antagonists among others.
This has been reported that by 2017, 15 million children die or affected annually by preventable or treatable heart disease in middle income and low income countries. In order to reduce the global burden of pediatric heart failure government is focusing on development of novel therapies and hence expected to provide market with the lucrative growth.
This pediatric heart failure market provides details of market share, new developments and product pipeline analysis, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Global Pediatric Heart Failure Market Scope and Market Size
Pediatric heart failure market is segmented on the basis of treatment, type, end-users and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of treatment, the pediatric heart failure market is segmented into diuretics, digoxin, aldosterone antagonists, ace inhibitors, beta blockers and inotropes.
- On the basis of type, the pediatric heart failure market is segmented into over- circulation failure and pump failure.
- On the basis of end-users, the pediatric heart failure market is segmented into clinics, hospitals, ambulatory surgical centers and others.
- On the basis of distribution channel, the pediatric heart failure market has also been segmented into hospital pharmacy, retail pharmacy, online pharmacy and others.
Pediatric Heart Failure Market Country Level Analysis
Pediatric heart failure market is analysed and market size information is provided by country, treatment, type, end-users and distribution channel as referenced above.
The countries covered in the pediatric heart failure market report are U.S., Canada, Mexico, Brazil, Argentina, Peru, Rest of South America, as part of South America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific, Saudi Arabia, U.A.E, Egypt, Israel, Kuwait, South Africa, Rest of Middle East and Africa, as a part of Middle East and Africa.
North America accounts the largest market share due to increasing incidence of pediatric heart failure in U.S. and increasing demand of effective therapies. Europe accounts the second largest market share due to vigorous research and development activities and enhanced drug distribution network. Asia-Pacific is expected to account for the largest market share over coming years for the pediatric heart failure market due to increasing awareness regarding pediatric heart failure and increasing government initiatives for improving the children health.
The country section of the report also provides individual market impacting factors and changes in regulations in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, disease epidemiology and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Patient Epidemiology Analysis
Pediatric heart failure market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the market in the growth period.
Competitive Landscape and Pediatric Heart Failure Market Share Analysis
Pediatric heart failure market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, company strengths and weaknesses, product launch, clinical trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the companies’ focus related to pediatric heart failure market.
The major players covered in the pediatric heart failure market are Pfizer Inc., Sanofi, Orion Pharma Ltd, Teva Pharmaceutical Industries Ltd, Olon S.p.A., Sun Pharmaceutical Industries Ltd., Alkaloids Corporation, C-squared PHARMA S.à r.l., Zhejiang Huahai Pharmaceutical Co., Ltd., Zhongfu Pharmaceutical Co.,Ltd., FARMHISPANIA GROUP, Cosmos Pharmaceutical, AdvaCare Pharma, RPG Life Sciences Limited, Nortec Quimica, POLPHARMA S.A., Cipla, Mylan N.V., Basic Pharma Life Science Pvt Ltd., RECORDATI S.p.A., among other domestic and global players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
SKU-
